These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Effect of bleeding during labor on the functional state of the anticlotting system in women. Kudryashov BA; Bogarada AN; Lyapina LA; Ul'yanov AM; Kaverina KP Hum Physiol; 1985; 11(2):143-7. PubMed ID: 4086037 [No Abstract] [Full Text] [Related]
8. [Circulating fibrin in patients with intravascular coagulation in obstetrics]. Graeff H; Hafter R; von Hugo R; Haas S; Stemberger A; Blümel G Arch Gynecol; 1979 Jul; 228(1-4):624. PubMed ID: 485518 [No Abstract] [Full Text] [Related]
9. [Changes in fibrinogen, fibrin-fibrinogen degradation products and fibrinolytic activity during pregnancy, labor and the puerperium in pregnant women with chronic hypertension]. Kendić S; Mujezinović O; Muratović H Med Arh; 2000; 54(1):29-31. PubMed ID: 10872273 [TBL] [Abstract][Full Text] [Related]
11. [State of the metabolic processes in pregnant women potentially inclined to a prolonged course of labor activity]. Shuĭkina EP; Kofman SG; Mandzik VS Vopr Okhr Materin Det; 1978 Aug; 23(8):82-5. PubMed ID: 695414 [No Abstract] [Full Text] [Related]
12. [Fibrin degradation products and complement levels in the blood of nephropathic children]. Penza R; Violante N; Brunetti L; Armenio L; Dibitonto G Pediatria (Napoli); 1975 Mar; 83(1):124-35. PubMed ID: 1223731 [No Abstract] [Full Text] [Related]
13. [Fibrinolytic activity in the blood of pregnant and parturient women during and after hemorrhage in the last trimester of pregnancy]. Poradovský K; Kendeová E Cesk Gynekol; 1973 Jun; 38(3):329-30. PubMed ID: 4717869 [No Abstract] [Full Text] [Related]
14. [Clinical value of determination of fibrin-fibrinogen degradation products in obstetrics and gynecology]. Krupko-Bol'shova IuA; Vork IB; Ana IaM; Glushchenko IV Akush Ginekol (Mosk); 1979 May; (5):8-10. PubMed ID: 382895 [No Abstract] [Full Text] [Related]
15. [Clinical value of determining fibrin and fibrinogen degradation products in kidney diseases]. Belitskaia GA; Ena IaM; Varetskaia TV; Shevchenko LI Klin Med (Mosk); 1976 Mar; 54(3):96-102. PubMed ID: 966670 [No Abstract] [Full Text] [Related]
16. Proceedings: Fibrin(ogen) breakdown products compared in mothers and their newborn infants. Graubner F; Kleine B; Beller FK Thromb Diath Haemorrh; 1975 Sep; 34(1):340. PubMed ID: 1188773 [No Abstract] [Full Text] [Related]
17. [Studies on intraglomerular coagulation in various renal diseases]. Shibata T Nihon Jinzo Gakkai Shi; 1985 Nov; 27(11):1535-47. PubMed ID: 3831470 [No Abstract] [Full Text] [Related]
18. [Use of certain selective chemical precipitation reactions of serum proteins in the study of normal and pathological pregnancies]. Morin P; Badin J; Abbou S; Yver AM; Ozil D J Gynecol Obstet Biol Reprod (Paris); 1977 Dec; 6(8):1077-90. PubMed ID: 75906 [No Abstract] [Full Text] [Related]
19. [Effect of fibrinogen degradation products on the functional state of the myometrium]. Malofiejew M Ginekol Pol; 1971; 42(12):1503-10. PubMed ID: 4258142 [No Abstract] [Full Text] [Related]
20. Comparison of a test for soluble fibrin polymer (TpP) with a standard quantitative ELISA for D-dimer in patients, without current thrombosis, who have cancer or renal disease. Arkel YS; Ku DH; Le P; Carr AM Thromb Haemost; 2001 Oct; 86(4):1127-8. PubMed ID: 11686342 [No Abstract] [Full Text] [Related] [Next] [New Search]